Welcome            

   French       Spanish        Arabic      Thai    

        

 

 About us   Products Patents   Investment  Employment   Contact us   

 

 

 

 

 

 

 

                   ~An Organization Dedicated in Prevention of Infectious Diseases 

      by Inventing Vaccines for Preventable Diseases for Infants, Children and Adults

 

 

JN is a global research-based company that develops and markets products to improve the health in more than 30 developing countries since 1998. JN is a leading innovation-driven Biopharmaceutical corporation. JN stands third in the World in developing Meningococcal meningitis (A, C, Y, W-135) polysaccharide vaccine for adults  & children and Stands Second in the World in providing Meningitis A, C, Y, W-135 Diphtheria conjugate meningococcal vaccine for infants.  JN is a partner of Global Health Organization, Clinton Global Initiative, and GBC. JN also partnering with  several other non-profit global health organizations, NGOs, local governments and communities in developing countries to address the health issues related to HIV/AIDS, Malaria, Tuberculosis and Bacterial Meningitis by underserved communities in West Africa, South East Asia and Latin Americas.  

 

 

Vaccine Products

Each year, millions of children and adults die and suffer from infectious diseases and disorders that could be prevented by current vaccines. JN-International investing to accelerate the development, supply and introduction of appropriate and affordable vaccines in impoverished countries.

 

Childhood and Adult Vaccines                                                       90-days Credit on LC


THIRD PART PRODUCTS             

Diphtheria and Tetanus Vaccine (Adult) &  (Pediatric)

Diphtheria, Tetanus, and Pertussis Vaccine (DTP Vaccine)

Polio plus Hb

Diphtheria, Tetanus, and Pertussis plus Hb

Measles, Mumps and Rubella (MMR) Vaccine

meningococcal meningitis A&C Vaccine 

 

JN's Meningococcal Vaccine Products for Africa and Hajji


JN dedicated in prevention of epidemic meningitis in sub-Saharan Africa through mass vaccination program.

 

(Disclaimer on meningococcal meningitis vaccines: The corporation cannot commit on availability of these products

because of uncertain on regulatory documentation and export approval for either finished product or for raw material and cost effective production .. JULY, 2008.)

 

NmVac4-A/C/Y/W135  

Meningococcal meningitis Serotypes A, C, Y, W135 for Adults & Children   

                                                            

NmVac4-A/C/Y/W135 DT

Meningococcal meningitis A,C,Y,W-135 Diphtheria Toxoid vaccine for infants 

Diagnostic Products 

 

Effective diagnostics are a crucial element of successful infectious disease management, yet their development and use, particularly in the developing world, remains a neglected area. To address this deficiency, JN produces user-friendly and low-cost and quality diagnostics for the developing world.

 

JN's Rapid and ELISA and Antigen test kits


JN-QC-Spot Rapid HIV, TB and Malaria

 

JN-QC- ELISA HIV and Hepatitis C kits

WORLD WIDE OFFICES

 

UNITED STATES OF AMERICA

 

6912 North 97th Circle, Omaha

Nebraska 68122

Tel. 402-884-3477; Fax. 402-614-4437

E-Mail:  drreddy@jn-vaccines.org

 

 

IVORY COAST

 

27 BP 71 ABIDJAN

 

Tel / Fax. 225.22.42.87.93

E-Mail:  drnoel@jn-vaccines.org

 

 

MALAYSIA

 

Kuala Lumpur  

Tel. to be announced 

E-Mail:  param@jn-vaccines.org

 

 

BURKINA FASO

 

Ouagadougou

Tel. 226.78.80.98.88

E-Mail:  Patrick@jn-vaccines.org

 

 

disclaimer of the corporation

Copyright 1998  JN-International, Inc., USA. All rights reserved